Disseminated cytomegalovirus infection complicating active treatment of systemic lupus erythematosus: An emerging problem

Lupus

Volumn 26, Issue 4, 2017, Pages 431-434

  Berman, N ^a   Belmont, H M ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Nephritis; renal lupus; systemic lupus erythematosus

Indexed keywords

ALBUMIN; AZATHIOPRINE; BELIMUMAB; CREATININE; CYCLOPHOSPHAMIDE; ENOXAPARIN; GANCICLOVIR; IMMUNOGLOBULIN; LUPUS ANTICOAGULANT; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; PHOSPHOLIPID ANTIBODY; PREDNISONE; RITUXIMAB; STEROID; ALKYLATING AGENT; ANTIMETABOLITE;

ACUTE KIDNEY FAILURE; ADULT; ANASARCA; ANTIPHOSPHOLIPID SYNDROME; ARTHRITIS; ARTICLE; ARTIFICIAL VENTILATION; BASAL GANGLION; BRAIN BIOPSY; BRONCHOSCOPY; CASE REPORT; CELL INCLUSION; CEREBRAL PEDUNCLE; CEREBROSPINAL FLUID; COLITIS; COLON BIOPSY; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; CYTOPENIA; DEHYDRATION; DEMYELINATION; DEPRESSION; DIARRHEA; DRUG DOSE REDUCTION; DRUG MEGADOSE; DYSPNEA; ENCEPHALITIS; FEMALE; FEVER; HEMIPARESIS; HEMIPLEGIA; HEMOPTYSIS; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HUMAN TISSUE; HYPERTRANSAMINASEMIA; HYPOCOMPLEMENTEMIA; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; JAMAICA; KIDNEY BIOPSY; LEUKOPENIA; LUMBAR PUNCTURE; LUNG HEMORRHAGE; LUPUS CEREBRITIS; LUPUS ERYTHEMATOSUS NEPHRITIS; LUPUS VULGARIS; LYMPHOCYTIC INFILTRATION; MAINTENANCE THERAPY; MALAR RASH; MENTAL HEALTH; MIDDLE AGED; MITRAL VALVE; NEPHRITIS; NEPHROTIC SYNDROME; OPEN LUNG BIOPSY; PANCOLITIS; PERICARDITIS; PLASMA EXCHANGE; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RASH; RESPIRATORY FAILURE; SCREENING TEST; SIGMOIDOSCOPY; STEROID THERAPY; SUICIDAL IDEATION; SYSTEMIC LUPUS ERYTHEMATOSUS; TERTIARY CARE CENTER; THROMBOTIC THROMBOCYTOPENIC PURPURA; VIREMIA; VIRUS LOAD; WEAKNESS; WEIGHT REDUCTION; ADVERSE EFFECTS; CYTOMEGALOVIRUS INFECTIONS; DISEASE MANAGEMENT; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; PROCEDURES; VIROLOGY;

ADULT; ALKYLATING AGENTS; ANTIMETABOLITES; CYTOMEGALOVIRUS INFECTIONS; DISEASE MANAGEMENT; FEMALE; HUMANS; IMMUNOSUPPRESSION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; STEROIDS;

EID: 85015807954     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203316671817     Document Type: Article

References (10)

1. Murray SG, Schmajuk G, Trupin L, et al. National lupus hospitalization trends reveal rising rates of Herpes zoster and declines in pneumocystis pneumonia. PLoS One 2016; Jan 5:11(1): e0144918-e0144918.
2. Bate SL, Dollard SC, Cannon MJ,. Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004. Clin Infect Dis 2010; 50: 1439-1447.
3. Razonable RR, Humar A,. Cytomegalovirus in solid organ transplantation. Am J Transplant 2013; 13: 93-106.
4. Valadkhana B, Karhar M, Ashouri A, et al. The risk factors for cytomyaglovirus reactivation following stem cell transplantation. J Res Pharm Pract 2016; 5: 63-69.
5. Wade JC,. Viral infection in patients with hematological malignancies. Am Soc Hematol 2006, pp. 368-373.
6. Kotton CN, Kumar D, Caliendo AM, et al. Updated international consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2013; 96: 333-360.
7. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. http://aidsinfo.nih.gov/guidelines (accessed 19 September 2016).
8. Price P, Makwana N, Brunt S (eds). Manifestations of cytomegalovirus infection. Intech, 2013.
9. Takizawa Y, Inokuma S, Tanaka Y, et al. Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population. Rheumatology 2008; 47: 1373-1378.
10. Singh N,. Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients. Clin Infect Dis 2001; 32: 742-751.